Variability of ZAP 70 expression in a patient with CLL.
Chaar
Bassem T
BT
Grosso
Leonard
L
Petruska
Paul J
PJ
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002880:Chromosomes, Human, Pair 11 / Q000235:genetics*; D002882:Chromosomes, Human, Pair 13 / Q000235:genetics*; D020732:Cytogenetic Analysis; D018450:Disease Progression; D005500:Follow-Up Studies; D015973:Gene Expression Regulation, Leukemic / Q000235:genetics*; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011379:Prognosis; D016896:Treatment Outcome; D051746:ZAP-70 Protein-Tyrosine Kinase / Q000096:biosynthesis / Q000235:genetics*
D051746:ZAP-70 Protein-Tyrosine Kinase; C497261:ZAP70 protein, human